FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

Historical Holders from Q3 2017 to Q1 2025

Symbol
FENC on Nasdaq
CUSIP
31447P100
Type / Class
Equity / Common Shares, no par value
Shares outstanding
27.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
16M
Holdings value
$101M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
64
Number of buys
37
Number of sells
-24
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Solas Capital Management, LLC 8.2% +17.1% $13.7M $1.99M 2.25M +17% Solas Capital Management, LLC Dec 31, 2024
DG Capital Management, LLC 4.1% $6.79M 1.11M DG Capital Management, LLC Dec 31, 2024

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 84.3K $513K -$5.02K $6.09 4
2024 Q4 16M $101M +$7.28M $6.32 64
2024 Q3 14.9M $74.7M +$2.54M $5.00 62
2024 Q2 14.4M $87.7M -$6.4M $6.11 62
2024 Q1 14.5M $161M -$5.97M $11.12 64
2023 Q4 15M $168M +$8.15M $11.22 54
2023 Q3 14.2M $107M +$1.44M $7.51 53
2023 Q2 14M $124M +$9.26M $8.83 53
2023 Q1 13M $108M +$4.62M $8.32 53
2022 Q4 12.5M $120M +$10.7M $9.60 42
2022 Q3 11.4M $92.1M +$2.92M $8.10 29
2022 Q2 112 $1K -$14K $4.71 1
2022 Q1 11.4M $64M +$541K $5.60 24
2021 Q4 11.3M $49.9M -$2.27M $4.40 25
2021 Q3 11.6M $110M -$3.02M $9.42 30
2021 Q2 12M $87.7M -$14.2M $7.29 36
2021 Q1 14.3M $89M -$487K $6.21 48
2020 Q4 14.5M $108M +$5.06M $7.45 48
2020 Q3 13.8M $83.8M -$965K $6.06 50
2020 Q2 13.9M $116M +$37.8M $8.35 52
2020 Q1 9.46M $56.2M +$983K $5.94 25
2019 Q4 9.29M $60.3M -$39.1K $6.48 25
2019 Q3 8.47M $40.7M -$1.96M $4.81 21
2019 Q2 8.99M $36M -$3.1M $4.00 25
2019 Q1 9.58M $46.5M -$672K $4.85 41
2018 Q4 9.7M $61.9M +$1.84M $6.38 40
2018 Q3 9.43M $77.4M -$275K $8.20 41
2018 Q2 9.39M $98.1M +$18.2M $10.44 42
2018 Q1 7.62M $92.2M +$5.66M $12.09 20
2017 Q4 6.95M $69.6M +$18M $9.97 13
2017 Q3 5.21M $57.7M +$57.7M $11.08 9